The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
88211133 8821113 3 F 20101022 20160905 20121002 20160909 EXP JP-GLAXOSMITHKLINE-B0833967A GLAXOSMITHKLINE 9.05 YR M Y 27.00000 KG 20160909 CN JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
88211133 8821113 1 PS LAMOTRIGINE. LAMOTRIGINE 1 Oral 20241 TABLET
88211133 8821113 2 SS LAMOTRIGINE. LAMOTRIGINE 1 Oral 20241 30 MG TABLET
88211133 8821113 3 SS LAMOTRIGINE. LAMOTRIGINE 1 Oral 20241 25 MG TABLET
88211133 8821113 4 SS LAMOTRIGINE. LAMOTRIGINE 1 Oral 20241 20 MG TABLET
88211133 8821113 5 SS LAMOTRIGINE. LAMOTRIGINE 1 Oral 20241 10 MG TABLET
88211133 8821113 6 SS LEVETIRACETAM. LEVETIRACETAM 1 Oral 125 MG, U Y 0 125 MG
88211133 8821113 7 SS LEVETIRACETAM. LEVETIRACETAM 1 Oral 250 MG, U Y 0 250 MG
88211133 8821113 8 SS LEVETIRACETAM. LEVETIRACETAM 1 Oral 500 MG, U Y 0 500 MG
88211133 8821113 9 SS LEVETIRACETAM. LEVETIRACETAM 1 Oral 750 MG, U Y 0 750 MG
88211133 8821113 10 C Mercazole CARBIMAZOLE 1 Oral U 0 2 MG TABLET QD
88211133 8821113 11 C Excegran ZONISAMIDE 1 Oral U 0 100 MG POWDER (EXCEPT [DPO]) BID
88211133 8821113 12 C Selenica-R VALPROATE SODIUM 1 Oral U 0 350 MG GRANULES BID
88211133 8821113 13 C MYSTAN CLOBAZAM 1 Oral U 0 4 MG ORAL POWDER QD
88211133 8821113 14 C MYSTAN CLOBAZAM 1 Oral U 0 6 MG ORAL POWDER
88211133 8821113 15 C MYSTAN CLOBAZAM 1 Oral U 0 8 MG ORAL POWDER
88211133 8821113 16 C DIAZEPAM. DIAZEPAM 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
88211133 8821113 1 Epilepsy
88211133 8821113 10 Hyperthyroidism
88211133 8821113 11 Epilepsy
88211133 8821113 12 Epilepsy
88211133 8821113 13 Epilepsy
88211133 8821113 16 Initial insomnia

Outcome of event

Event ID CASEID OUTC COD
88211133 8821113 HO
88211133 8821113 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
88211133 8821113 Abasia
88211133 8821113 Abnormal behaviour
88211133 8821113 Asterixis
88211133 8821113 Electroencephalogram abnormal
88211133 8821113 Feeding disorder
88211133 8821113 Gait disturbance
88211133 8821113 Hypotonia
88211133 8821113 Initial insomnia
88211133 8821113 Lethargy
88211133 8821113 Poor quality sleep
88211133 8821113 Poverty of speech
88211133 8821113 Sleep phase rhythm disturbance
88211133 8821113 Somnolence
88211133 8821113 Status epilepticus
88211133 8821113 Tonic convulsion

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
88211133 8821113 1 20100723 20101007 0
88211133 8821113 2 20101008 20101226 0
88211133 8821113 3 20101227 20110106 0
88211133 8821113 4 20110107 0